期刊文献+

子宫内膜异位症诊治的基础研究进展 被引量:4

The Diagnosis and Treatment Progress of Endometriosis in the Fundament Research
下载PDF
导出
摘要 子宫内膜异位症(EMs)是育龄妇女的常见病。近年EMs相关基础研究深入而广泛,EMs发病特异性基因的筛查、蛋白质组学和EMs疼痛机制的研究,为该症的诊断提供了新的生物学指标和途径。EMs干细胞的研究、基因治疗、抗血管生成治疗及新型激素抑制药的应用,为EMs的治疗开阔了思路,促进了临床诊断方法的更新及治疗手段的改革。 Endometriosis is an common disease of reproductive age women.The fundament research of endometriosis is more extensive and deep in recent years,screening the specificity virulence gene of EMs,studying the proteome and pain mechanism of EMs,provided the new biological parameter and pathway for the EMs diagnosis.The study of stem cell of EMs,the application of gene therapy,the antiangiogenesis and new type hormone suppressant on EMs,broad the new way for the therapy of EMs.All these facilitate the renovation of clinical diagnosis and reform of treatment in Endometriosis.
作者 邹杰 李亚里
出处 《国际妇产科学杂志》 CAS 2010年第6期405-408,共4页 Journal of International Obstetrics and Gynecology
关键词 子宫内膜异位症 诊断 干细胞 疼痛测定 治疗 临床研究性 Endometriosis Diagnosis Stem cells Pain measurement Therapies investigational
  • 相关文献

参考文献1

二级参考文献10

  • 1The American Fertility Society. Revised American Fertility Society classification of endometriosis : 1985. Fertil Steril, 1985,43 : 351- 352.
  • 2Seibert V, Ebert MP, Buschmann T. Advances in clinical cancer proteomics : SELDI-TOF-mass spectrometry and biomarker discovery. Brief Funct Genomic Proteomic ,2005,4 : 16-26.
  • 3Abrao MS, Podgaec S, Filho BM, et al. The use of biochemical markers in the diagnosis of pelvic endometriosis. Hum Reprod, 1997,12:2523-2527.
  • 4Bedaiwy MA, Falcone T. Laboratory testing for endometriosis. Clin Chim Acta, 2004,340:41-56.
  • 5Telimaa S, Kauppila A, Ronnberg L, et al. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high- dose medroxyprogesterone acetate. Am J Obstet Gynecol, 1989, 161:866-871.
  • 6Gupta S, Agarwal A, Sekhon L, et al. Serum and peritoneal abnormalities in endometriosis : potential use as diagnostic markers. Minerva Ginecol,2006,58:527-551.
  • 7Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod, 2002,17:426-431.
  • 8Abrao MS, Podgaec S, Pinotti JA, et al. Tumor markers in endometriosis. Int J Gynaecol Obstet,1999,66 : 19-22.
  • 9Somigliana E, Vigano P, Tirelli AS, et al. Use of the concomitant serum dosage of CA125, CA199 and interleukin--6 to detect the presence of endometriosis-results from a series of reproductive age women undergoing laparoscopic surgery for benign gynecological conditions. Hum Reprod,2004, !9 : 1871-1876.
  • 10范乃军,高春芳,王秀丽,盛新华,李冬晖,郑国宝.应用SELDI-TOF-MS技术初步建立结直肠癌分类树模型[J].世界华人消化杂志,2009,17(1):53-58. 被引量:4

共引文献5

同被引文献42

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部